NewAmsterdam Pharma Stock (NASDAQ: NAMS) stock price, news, charts, stock research, profile.
Open | $18.670 |
Close | $18.750 |
Volume / Avg. | 547.724K / 171.946K |
Day Range | 18.150 - 19.618 |
52 Wk Range | 5.633 - 26.350 |
Market Cap | $1.687B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 0.52% |
Days to Cover | 2.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NewAmsterdam Pharma (NASDAQ: NAMS) through any online brokerage.
Other companies in NewAmsterdam Pharma’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Xencor (NASDAQ:XNCR), Protagonist Therapeutics (NASDAQ:PTGX) and Bicycle Therapeutics (NASDAQ:BCYC).
The latest price target for NewAmsterdam Pharma (NASDAQ: NAMS) was reported by TD Cowen on Wednesday, May 15, 2024. The analyst firm set a price target for 0.00 expecting NAMS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for NewAmsterdam Pharma (NASDAQ: NAMS) is $18.75 last updated May 31, 2024 at 4:00 PM EDT.
There are no upcoming dividends for NewAmsterdam Pharma.
NewAmsterdam Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for NewAmsterdam Pharma.
NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.